The Stocktwits and Twitter KBIO message boards are on fire again, as KBIO spring boards back into euphoria, ahead of the CEOs interview with Bloomberg at 1pm.
Ok, that’s it. There isn’t any medical news forthcoming or some ground breaking devlopments or ventures about to take place. No. The only reason why the stock is higher is because its oddball CEO is going on the teevee at 1pm.
Oh, and there’s still a bunch of “the next KBIOs” going on over there, pointing to share prices action in GENE, AEZS and MCUR as hard evidence.
Fucking morons. You’re all gonna blow yourselves up.
If you enjoy the content at iBankCoin, please follow us on Twitter
I’m gonna pass on those and blow myself up in $STRP.
I done blowed meself up already in SUNE
Fly, reading your story about how you were early to dot.com Internet party and played it like an absolute boss, is there any advice/experience you can pass on to investors and traders in the biotech space about how to distinguish actual money making companies vs. pure R&D expense shops?
Of course revenue growth, FDA approvals, partnerships with larger pharma, etc. are good places to start, but do you have any unique insights as to any specific fundamental or intangible qualities and characteristics. Thank you ahead of time, and Happy Thanksgiving good sir.
boyaj
Truth is, most of the money I made in dot coms were in stocks that eventually went to zero. The key to trading a bubble is to be first, bold, and fearless. The second you start to doubt yourself, you already lost the momo trade.’
This biotech run reminds me of the dot coms. Most people don’t talk about the mean draw downs during the dot com bubble. It was just as bad as the one in biotech now.
Thanks Fly, that’s invaluable advice. As I’ve indicated before, my strength isn’t in trading but much more so in investing. That being said, getting a different perspective, learning, and taking in as much as I can is essential to succeed in this game. I appreciate the insight here, as well as the pure transparency and candor.
1
The next KBIO, i.e. the next company that goes bankrupt then has some personality buy 40% of it to take his company public. Probably not gonna see the next KBIO for 10 years.